GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (STU:8AK) » Definitions » Ending Cash Position

Alkermes (STU:8AK) Ending Cash Position : €387 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Alkermes Ending Cash Position?

Alkermes's Ending Cash Position for the quarter that ended in Mar. 2024 was €387 Mil.

Alkermes's quarterly Ending Cash Position declined from Sep. 2023 (€607 Mil) to Dec. 2023 (€419 Mil) and declined from Dec. 2023 (€419 Mil) to Mar. 2024 (€387 Mil).

Alkermes's annual Ending Cash Position declined from Dec. 2021 (€299 Mil) to Dec. 2022 (€276 Mil) but then increased from Dec. 2022 (€276 Mil) to Dec. 2023 (€419 Mil).


Alkermes Ending Cash Position Historical Data

The historical data trend for Alkermes's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkermes Ending Cash Position Chart

Alkermes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 183.39 224.37 298.73 276.10 419.50

Alkermes Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 300.19 614.53 606.91 419.50 387.09

Alkermes Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Alkermes's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=268.198+151.301
=419

Alkermes's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=420.872+-33.779
=387


Alkermes Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Alkermes's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkermes (STU:8AK) Business Description

Traded in Other Exchanges
Address
1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Alkermes (STU:8AK) Headlines

No Headlines